Gerresheimer performance levels simplify choice of optimum solution
Three performance levels for injection vials, syringes, ampoules and cartridges Clear and consistent structure for s…
Three performance levels for injection vials, syringes, ampoules and cartridges Clear and consistent structure for s…
Bavarian Nordic A/S (OMX: BAVA) announced today that JYNNEOS®, the only FDA-approved mpox vaccine, is now commercially a…
Interim clinical data update on ACTengine® IMA203 GEN1 (PRAME) in melanoma at RP2D in November 2023: 50% confirmed objec…
Bavarian Nordic A/S (OMX: BAVA) announced today that the Swiss Agency for Therapeutic Products, Swissmedic, has approved…
The term “biotherapies” broadly refers to medicinal products, including biopharmaceuticals, that are produced from biolo…
The constant temperature equipment manufacturer LAUDA is launching a new product on the market to start the new year: th…
Messenger RNA (mRNA) nanomedicines, a ground-breaking technology that has led to the development of the first approved C…
Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results for the first nine months of 2023 and busi…
New partnership will harness Moderna’s mRNA rapid-response platform, clinically validated during the COVID-19 pandemic,…
. New agreement to establish global commercial manufacturing capacity for Vaxcyte's PCV candidates, VAX-24 and VAX-31,…